SCHEMBL13633872

SCHEMBL13633872

CCc1nc(-c2ccsc2)oc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.48
PPARG P37231 3/20 0.48
IKBKB O14920 1/20 0.42
KDM4E B2RXH2 4/20 0.41
RAB9A P51151 1/20 0.39
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
KDM1A O60341 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPGD P15428 1/20 0.36
CYP2A6 P11509 1/20 0.36
HSD17B10 Q99714 1/20 0.35
GPR119 Q8TDV5 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12163729 0.86 PPARA (0.45) PPARAPPARGIKBKBKDM4ECDC7
SCHEMBL13633892 0.80 IKBKB (0.50) PPARAPPARGIKBKBKDM4ECDC7
SCHEMBL266619 0.76 KDM4E (0.66) PPARAPPARGKDM4ERAB9AKDM1A
SCHEMBL13503414 0.76 TARBP2 (0.53) PPARAPPARGKDM4ERAB9AMEN1
SCHEMBL12961041 0.73 ALDH1A1 (0.52) PPARAPPARGKDM4ERAB9AMEN1
SCHEMBL13179907 0.73 HSD17B10 (0.58) PPARAKDM4ERAB9AMEN1POLB
SCHEMBL9097470 0.73 ESR1 (0.50) KDM4ERAB9APOLBHPGDHSD17B10
SCHEMBL5209327 0.73 KDM1A (0.46) PPARAPPARGKDM4ERAB9AKDM1A
SCHEMBL13633897 0.72 KDM4E (0.57) KDM4ERAB9AKDM1AMEN1POLB
SCHEMBL13633793 0.71 KDM4E (0.54) PPARAPPARGKDM4ERAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275565-A1 Substituted aralkyl derivatives CADILA HEALTHCARE LIMITED (IN) 2009-11-05 US disclosed
US-20090275565-A1 Substituted aralkyl derivatives CADILA HEALTHCARE LIMITED (IN) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275565-A1 Substituted aralkyl derivatives UGT1A7, UGT1A10, UGT2B7 PPARA 2339/4885PPARG 2043/4885IKBKB 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.